4//SEC Filing
Griggs Jonathan 4
Accession 0001209191-12-030343
CIK 0001087294other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:47 PM ET
Size
9.6 KB
Accession
0001209191-12-030343
Insider Transaction Report
Form 4
Griggs Jonathan
Director
Transactions
- Disposition to Issuer
Options
2012-05-22−1,600→ 0 totalExercise: $9.00From: 2005-12-15Exp: 2015-12-15→ Common stock (1,600 underlying) - Disposition to Issuer
Options
2012-05-22−1,000→ 0 totalExercise: $13.00From: 2009-02-16Exp: 2019-02-16→ Common stock (1,000 underlying) - Award
Restricted stock
2012-05-22$6.41/sh+945$6,057→ 945 totalExercise: $0.00From: 2013-05-22→ Common stock (945 underlying)
Footnotes (2)
- [F1]Restricted shares acquired in exchange for options tendered as part of the Exchange Program that ended on May 21, 2012.
- [F2]Restricted stock does not expire.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001490828
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 5:47 PM ET
- Size
- 9.6 KB